Print

Brainsway (BRSYF.PK) Announces Final Results in Clinical Trial for Smoking Cessation in Chronic Obstructive Pulmonary Disease Patients  
1/25/2013 9:00:26 AM

JERUSALEM, Jan. 24, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) ("Brainsway" or the "Company) is pleased to announce that it has received final results with respect to a clinical trial that was conducted at the Be'er Ya'akov Mental Health Center to assess the efficacy of the Company's Deep TMS device in inducing smoking cessation in chronic obstructive pulmonary disease ("COPD") patients using a specialized coil developed for this purpose.
//-->